阿维A联合雷公藤多甙治疗掌跖脓疱病疗效观察
摘要
背景：掌跖脓疱病是一种病因尚未完全明了的发生于掌跖部位的慢性、复发性、炎症性疾病。多数人认为免疫学介导的发病机制在掌跖脓疱病的发生上起着重要的作用，但也有人认为本病是一种局限性脓疱型银屑病。本病的典型临床表现是在红斑基础上周期性发生的深在无菌性小脓疱,伴角化、脱屑。治疗方法多样主要有维甲酸类、免疫抑制剂、生物调节剂，抗生素类以及物理疗法，但疗效都不十分满意。阿维A联合雷公藤多甙治疗掌跖脓疱病的国内相关报道较少。
目的：观察阿维A联合雷公藤多甙治疗掌跖脓疱病疗效和安全分析。
方法：搜集门诊患者102例，随机分成三组：分别为阿维A联合雷公藤多甙组、阿维A组、雷公藤多甙组，同时均外用复方丙酸氯倍他索软膏（商品名：金纽尔）疗程2月，然后根据各项治疗指标进行比较。
结果：阿维A联合雷公藤多甙组治疗2个月后有效率明显高于另外两组（阿维A联合雷公藤多甙组为92.31%，阿维A组为64.52%，雷公藤多甙组为62.5%），阿维A联合雷公藤多甙组与阿维A组相比（X~2=9.092，P=0.028<0.05）差异有统计学意义；阿维A联合雷公藤多甙组与雷公藤多甙组相比（X~2=11.084，P=0.011<0.05）差异有统计学意义；阿维A组与雷公藤多甙组相比（X~2=0.575，P=0.902＞0.05)差异无统计学意义。
结论：与单用阿维A或者雷公藤多甙相比两药联合应用治疗掌跖脓疱病疗效高，不良反应无明显增加。
Background: palmoplantar pustulosis is a disease that have still not fullyunderstand its pathogeny, occurs in the palms and soles, it is a chronic,relapsing, inflammatory disease. Most people think that the pathogenesis ofimmunology plays an important part in palmoplantar pustulosis, but also somepeople think that the disease is localized pustular psoriasis.The typical clinicalperformance is small, sterile, deeply pustules occurred periodic based inerythema, with keratinize and take off bits. Treatment methods are various，forexample Tretinoin、immunosuppressive agents、biological regulator、antibiotic and physical therapy，but curative effect is still not quite satisfiedwith.The report about palmoplantar pustulosis treated with Acitretin andTripterygium Glycosides is rarely.
Objective：To observe the efficacy of palmoplantar pustulosis treated withAcitretin and Tripterygium Glycosides.
Methods:102out-patients were randomly divided into3groups whichwere treated by Acitretin and Tripterygium Glycosides, Acitretin,Tripterygium。At the same time all use compound clobetasol propionate ointment externally intwo months，and then to compare treatment datas。
Results: The effective rate of Acitretin and Tripterygium Glycosides groupis higher than the other two groups in2weeks later(The effective rate ofAcitretin and Tripterygium Glycosides group is92.31%, Acitretin group is64.52%and Tripterygium Glycosides group is62.5%)。 Acitretin and TripterygiumGlycosides group to Acitretin group is X~2=9.092，P=0.028<0.05, there arestatistically significant differences between the two groups; Acitretin and Tripterygium Glycosides group to Tripterygium Glycosides group is X~2=11.084，P=0.011<0.05, there are statistically significant differences between the twogroups; Acitretin group to Tripterygium Glycosides group is X~2=0.575，P=0.902＞0.05, there are no statistically significant differences between the twogroups.
Conclusion: Compared to the other two groups，the curative effect ofpalmoplantar pustulosis treated with Acitretin and Tripterygium Glycosides isvery good，and side effect without increased significantly.
目的：观察阿维A联合雷公藤多甙治疗掌跖脓疱病疗效和安全分析。
方法：搜集门诊患者102例，随机分成三组：分别为阿维A联合雷公藤多甙组、阿维A组、雷公藤多甙组，同时均外用复方丙酸氯倍他索软膏（商品名：金纽尔）疗程2月，然后根据各项治疗指标进行比较。
结果：阿维A联合雷公藤多甙组治疗2个月后有效率明显高于另外两组（阿维A联合雷公藤多甙组为92.31%，阿维A组为64.52%，雷公藤多甙组为62.5%），阿维A联合雷公藤多甙组与阿维A组相比（X~2=9.092，P=0.028<0.05）差异有统计学意义；阿维A联合雷公藤多甙组与雷公藤多甙组相比（X~2=11.084，P=0.011<0.05）差异有统计学意义；阿维A组与雷公藤多甙组相比（X~2=0.575，P=0.902＞0.05)差异无统计学意义。
结论：与单用阿维A或者雷公藤多甙相比两药联合应用治疗掌跖脓疱病疗效高，不良反应无明显增加。
Background: palmoplantar pustulosis is a disease that have still not fullyunderstand its pathogeny, occurs in the palms and soles, it is a chronic,relapsing, inflammatory disease. Most people think that the pathogenesis ofimmunology plays an important part in palmoplantar pustulosis, but also somepeople think that the disease is localized pustular psoriasis.The typical clinicalperformance is small, sterile, deeply pustules occurred periodic based inerythema, with keratinize and take off bits. Treatment methods are various，forexample Tretinoin、immunosuppressive agents、biological regulator、antibiotic and physical therapy，but curative effect is still not quite satisfiedwith.The report about palmoplantar pustulosis treated with Acitretin andTripterygium Glycosides is rarely.
Objective：To observe the efficacy of palmoplantar pustulosis treated withAcitretin and Tripterygium Glycosides.
Methods:102out-patients were randomly divided into3groups whichwere treated by Acitretin and Tripterygium Glycosides, Acitretin,Tripterygium。At the same time all use compound clobetasol propionate ointment externally intwo months，and then to compare treatment datas。
Results: The effective rate of Acitretin and Tripterygium Glycosides groupis higher than the other two groups in2weeks later(The effective rate ofAcitretin and Tripterygium Glycosides group is92.31%, Acitretin group is64.52%and Tripterygium Glycosides group is62.5%)。 Acitretin and TripterygiumGlycosides group to Acitretin group is X~2=9.092，P=0.028<0.05, there arestatistically significant differences between the two groups; Acitretin and Tripterygium Glycosides group to Tripterygium Glycosides group is X~2=11.084，P=0.011<0.05, there are statistically significant differences between the twogroups; Acitretin group to Tripterygium Glycosides group is X~2=0.575，P=0.902＞0.05, there are no statistically significant differences between the twogroups.
Conclusion: Compared to the other two groups，the curative effect ofpalmoplantar pustulosis treated with Acitretin and Tripterygium Glycosides isvery good，and side effect without increased significantly.
引文
[1]李兴文,李萍,闫树河等.金属宫内节育器致掌跖脓疱病10例[J].临床皮肤科杂志,2001,30(1):57.
[2]李世德,张荣良,刘忠新.镍铬合金固定义齿致掌跖脓疱病一例[J].临床皮肤科杂志,1998,27(5):332
[3]皮超..金属节育环导致下唇剧痒27年一例[J].皮肤病与性病,2007,29(1):58
[4]段文利.协和医院首例报道铜过敏所致掌跖脓疱病.中国医药报,2009年1月13日第A04版
[5]倪容之主编,现代皮肤病治疗学[M].人民军医出版社,1994,500
[6] Nozawa H, Kishibe K, Takahara M,et al. Expression of cutaneouslymphocyte-associated antigen (CLA) in tonsillar T-cells and its inductionby in vitro stimulation with alpha-streptococci in patients with pustulosispalmaris et plantaris (PPP)[J].Clin Immunol,2005,116(1):42-53.
[7] Hubner AM,Tenbaum SP.Complete remission of palmoplantar pustulosisthrough Helicobacyer phlori eradication: a case report[J]. Clin ExpD-ermatol,2008,33(3):339-340
[8]马绍云,窦国华.中西医结合治疗掌跖脓疱病46例临床观察[J].甘肃中医,2001,14(10):45
[9]刘洪普,黄秀红.中医药治疗掌跖脓疱病研究进展.山东医药大学学报,2008,32(2):175-176.
[10]王争胜.六味洗剂配合窄谱UVB照射治疗掌跖脓疱病的疗效观察[J].甘肃中医学院学报,2010,27(4):42-43.
[11]张枫.人咬伤诱发掌跖脓疱病一例[J].皮肤病与性病,2005,27（2）：60.
[12] Cohen JD, Bournerias I, Buffar V, et al. Psoriasis induced by tumornecrosis factor-α antagonist therapy: a case series[J]. J Rheumatol,2007,34(2):380-385.
[13]张壤之,王景权.一家四代10人同患掌跖脓疱病[J].皮肤病与性病,1998,20(2):39.
[14] Edlund E, Johnsson U, Lidgren L, et al. Palmoplantar pustulosis andsternocostoclavicular arthro-osteitis[J]. Ann Rheum Dis,1988:47(10):809–815.
[15] Nymann P, Kollerup G, Jemec GBE, Grossmann E.Decreased bonemineral density in patients with pustulosis palmaris et plantaris[J].Dermatology,1996:192(4):307–311.
[16] Saez-Rodriguez M, Noda-Cabrera A, Garcia-Bustinduy M, Gul-meraMar-tin-Neda F, Dorta-Alom S, Escoda-Garcia M,et al. Palmo-plantar pustu-losis associated with gastric Helicobacter pyloriinfection[J]. Clin Exp Dermatol,2002:27(8):720.
[17] O’Doherty CJ, MacIntyre C. Palmoplantar pustulosis and Smoking[J].BMJ (Clinical Research Ed),1985:291(6499):861–864.
[18] Saez-Rodriguez M, Noda-Cabrera A, Alvarez-Tejera S, Gulmer-aMartinNeda F, Dorta-Alom S, Escoda-Garcia M,et al. The role ofpsychological factors in palmoplantar pustulosis [J].J Eur Acad Derma-tolVenereol,2002:16(4):325–327.
[19] Camp RDR. Champion RH, et al. Psoriasis In:Textbook of Dermatology.6thed. Oxford: Blackwell Science,1998.1589-1649.
[20]王侠生,廖康煌.杨国亮皮肤病学[M].上海:上海科学技术出版社,2005:582-583.
[21]杨明霞,杨维玲,李鹤玉,等.掌跖脓疱病不属于银屑病几种疾病外周血单核细胞对OK-432增殖反应的比较[J].哈尔滨医科大学学报,2009,43(4):368-371
[22]李秉煦,麦幕霞,郭丙堂.掌跖脓疱病免疫学观察[J].临床皮肤科杂志,1990(19):231-232.
[23]商刚，姚大芳.中草药治疗掌跖脓疱病临床疗效的理论研究[J].航空航天医药,2000,11(2):66-69.
[24]曹海鹏,朱桢,齐凤琴,富学东.复方甘草酸苷片联合复方氟米松软膏治疗掌跖脓疱病45例疗效观察[J].中国煤炭工业医学杂志,2010,13(3):428-429.
[25]刘俊礼,赵荣涛.掌跖脓疱病患者免疫指标测定及其意义[J].吉林医学院学报,1999,19(1):27-29.
[26] Torii H,Nakagawa H, Ishibashi Y,et al. Genetic polymorphisms in thefourth component of complement (C4) and in properdin factor B (BF) inJapanese patients with palmoplantar pustulosis[J]. J Dermatol,1992,19(6):353-355.
[27]吴秀忠，郭高田，王应俊等.环孢素A治疗掌跖脓疱病及血清细胞因子检测[J].中华皮肤科杂志,1997，30（2）：135.
[28] Rosen K, Jontell M, Mobacken H, et al. Epidermal Langerhans cells inpatients with pustulosis palmop-lantaris treated with etretinate oretretinate methoxsalen photochemotherapy[J]. Acta Derm Venereol,1988,68(3):218-223.
[29]史飞,赵庆利,王毅侠等.蔡瑞康教授治疗掌跖脓疱病经验[J].中国中西医结合皮肤性病学杂志,2004,3(4):196-197
[30]乔宏,刘灵,马栓全.无菌性脓疱类皮肤病中医治疗体[J].现代中医药,2006,26(1):13-14.
[31]王禾,王萍,陈凯.辨证治疗掌跖脓疱病18例[J].北京中医,2004,23(4):223-224.
[32]马怀东，田连迎.活血清热散治疗掌跖脓疱病60例[J].河北中医,2001：23(9):672.
[33] Sonozaki H, Kawashima M, Hongo O, et al. Incidence of arthroosteitis inpatients with pustulosis palmaris et plantaris [J]. Ann Rheum Dis,1981,40(6):554-557.
[34]张江林,黄烽.掌跖脓疱病性关节炎影像学表现[J].中国医学影像技术,2005,21(9):1427-1429.
[35]屈丽娜，邵娟，张福仁.掌跖脓疱病伴胸肋关节炎1例[J].实用皮肤病学杂志,2009,2(3):132.
[36]曹宇，闵仲生，张美华.掌跖脓疱病伴发前胸壁综合症[J].临床皮肤科杂志,2010,39(5):294-296
[37]杨蓉娅,唐玉，王文岭，等.掌跖脓疱病伴骨关节损害2例[J].临床皮肤科杂志，2001,30(1):49。
[38] Hagforgen E,Michalsson K,Lundgren E et al.Women with palmoplanterpustulosis have disturbed calcium homeostasis and a high prevalence ofdiabetes mellitus and psychiatric disorders: A case control study [J].Dermatology,2005,1(8):40-41．
[39]刘东海.甲亢伴掌跖脓疱病1例[J].罕少疾病杂志，2004.11(1):59-60.
[40]杨克健,惠艳.维胺脂胶囊治疗掌跖脓疱病疗效观察[J].中华皮肤科杂志,2003,36(4):220.
[41]李媛媛，钟文俊，池丽俏.异维A酸联合雷公藤治疗掌跖脓疱病疗效观察.中国社区医师,16版.
[42]徐薇，杨高云，赵俊英.异维A酸胶丸合并卤米松软膏治疗掌跖脓疱病临床疗效观察[J].中国医刊,2010,45(9):63-64.
[43] Wiegand UW, Chou RC. Pharmacokinetics of acitretin and etretinate [J]. JAm Acad Dermatol,1998,39(2):25-33.
[44] Gerger JM. Efficacy of acitretin in severe psoriasis[J]. Skin therapyletter,2003,8(4):1-3,7.
[45] GronhojLarsen F, SteinkjerB, Jakobsen P,et al. Acitretin is converted toetretinate only during concomitant alcohol intake [J]. Br J Dermatol,2000,143(6):1164-1169.
[46]庞晓文,王玉颖,赵密萍.阿维A治疗掌跖脓疱病临床疗效观察[J].临床皮肤科杂志,2007,36(2):117
[47] Rood MJ, Lavrijsen SP, Huizinga TW. Acitretinrelated Ossification [J].JRheumatol,2007,34(4):837-838.
[48] West MR, Page JM, Turner DM, et al. Simple assays of retinoid activity aspotential screens for compounds that may be useful in treatment ofpsoriasis[J]. J Invest Dermatol,1992,99(1):95-100.
[49]郭英军,李远宏,夏丽新,陈洪铎.芳维A酸乙酯胶囊治疗无菌性脓疱性皮肤病疗效观察[J].中国麻风皮肤病杂志,2007,23(3）：222-223.
[50]陈世义,李晓红,刘兵,马刚.芳维A酸乙酯治疗掌跖脓疱病临床分析[J].吉林大学学报,2003,39(4):504.
[51] Kumada H.Long-term treatment of chronic hepatitis C with glycyrrhizinin stronger neo-minophagen C(SNMC) for preventing liver cirrhosis andhepatocellular carcinoma[J]. Oncology,2002,62Suppl:94–100.
[52] Kroes BH, Beukelman CJ,Vanden Berg AJ, et al. Inhibition of humancomplement by beta glycyrrhetimic acid[J]. Immunology,1997,90(1):115-120.
[53]李萍,冯世军,马敬,王雪燕.复方甘草酸苷片治疗掌跖脓疱病疗效观察[J].河北中医,2007,29(8)742-743.
[54]孙鹤春,姜洪起,于延.复方甘草酸苷联合雷公藤治疗掌跖脓疱病疗效观察[J].中国皮肤性病学杂志,2008,22(8):475-476.
[55]安洪艳,雷公藤多甙治疗掌跖脓疱病临床疗效观察[J].中国冶金工业医学杂志,2008,25(5):572.
[56]张彪.掌跖脓疱病治疗现状[J].中国误诊学杂志,2010,10(31):7577-7579.
[57]朱学骏,顾有守,沈丽玉.实用皮肤性病治疗学[M],北京:北京医科大学中国协和医科大学联合出版社,1996:59-60.
[58]吴秀忠,郭高田,王应俊,于天周,肖国民.环孢素A治疗掌跖脓疱病及血清细胞因子检测[J].中华皮肤科杂志,1997,30(2):135.
[59]刘春梅,丁秋允,赵建伟，等.卡介苗素联合复方青黛胶囊治疗掌跖脓疱病临床观察[J].中国麻风皮肤病杂志,2007,23(7):640.
[60]邓列华，林泽，陈贤丰.左旋咪唑治疗掌跖脓疱病[J].岭南皮肤性病科杂志,1995,(4):17-18.
[61] Kanda N, Enomoto U, Watanabe S.Anti-mycotice suppress in terleukin-4and interleukin-5production in anti-CD3plus anti-CD28-stimulated Tcells from patients with atopic dermatitis[J].J Invest Dermatol,2001,117(6):1635-1646.
[62]姚志远，尤立平，张立新，等.伊曲康唑治疗掌跖脓疱病临床观察[J].临床皮肤科杂志,2004,33(7):441-442.
[63]庞晓文,杨雪琴,江丽,等.甘草酸二胺联合米诺环素治疗掌跖脓疱病[J].中华皮肤科杂志,2002,35(6):438.
[64] Owen CM, Chalmers RJ, Sullivan T, et al. Antistreptococcal interventionsfor guttate and chronic plaque psoriasis. Cochrane Database Syst Rev,2000:(2):CD001976.
[65]姜红军，甲砜霉素治疗掌跖脓疱病41例[J].中国皮肤性病学杂志,2007，21(7)：440
[66]王亮春,赵天恩.氨苯砜的皮肤科临床应用新进展[J].皮肤病与性病,2001,23(1):21.
[67]沈敏娟,匡钱华.黄柏洗剂治疗掌跖脓疱病60例[J].中华皮肤科杂志,2003,36(2):106.
[68]刘拥军,张健,李淑莲等.中药复方二白洗剂治疗掌跖脓疱病临床研究[J].中医药信息,2004,21(3):61-62.
[69]张春红,杜锡贤,张春敏.清热利湿饮治疗掌跖脓疱病35例[J].中国中西医结合皮肤性病学杂志,2004,(2):109.
[70]崔德彬,鲍海平.中西医结合治疗掌跖脓疱病50例疗效观察[J].中国皮肤性病学杂志,2006,20(7):419
[71] Duvic M, Asano AT, Hager C, et al. The pathogenesis of psoriasis andthe mechanism of action of tazarotene[J]. J Am Acad Dermatol,1998,39(4):129-133.
[72] Krochmal L, Wang JC, Patel B,et al.Topical corticosteroid compo-unding:effects on physicochemical stability and skin penetration rate [J].J Am Acad Derm,1989,21(5):979-984.
[73] Matsumoto K, Hashimoto K, Kiyoki M, et al. Effect of1,24Rdihy-droxyvitamin D3on the growth of human keratinocytes [J]. J Dermatol,1990,17(2):97-103.
[74]范雪莉,郑家润.1,25-二羟维生素D3和钙泊三醇对表皮细胞的免疫抑制作用[J].国外医学·皮肤性病学分册,1995,21(4):247-248.
[75]张俊，胡飞虎，郦黎明,等.他卡西醇软膏治疗27例掌跖脓疱病疗效观察[J].临床皮肤科杂志,2007,36(5):328-329.
[76]赵文，曹玉平.钙泊三醇加卤米他松封包治疗限局性无菌性脓疱病61例[J].中国医师进修杂志,2006,29(2):40-41.
[77]赵延海,杨红,刘轶平.窄谱中波紫外线治疗掌跖脓疱病疗效观察[J].中国中西医结合皮肤性病学杂志,2005,4（3）:187.
[78]李艳阳，杨学武，隋薇.窄谱中波紫外线照射治疗掌跖脓疱病疗效观察[J].中国麻风皮肤病杂志,2006,22(7):612.
[79]杨宝琦,赵娜,张福仁.银屑病光疗和光化学疗法的研究进展[J].中华皮肤科杂志,2005,38(3):195-197.
[80]张彪，兰广萍，胡本超，时念成.局部PUVA治疗掌跖脓疱病8例[J].中国麻风皮肤病杂志,2005,21(6):495.
[81]张宝牛,刘炯.90Sr-90Y敷贴器治疗掌跖脓疱病的临床应用[J].临床医药实践杂志,2007,16(7):593-584.
[82]尹伯元.临床核素治疗学[M].北京:人民军医出版社,2003:234-238.
[83]韩秀玲,刘业兰,周光英.得宝松穴位注射治疗掌跖脓疱病40例报告[J].山东医药,2007,47(6):39.
[84]邓文霞.曲安缩松穴位注射治疗掌跖脓疱病56例观察与护理[J].齐鲁护理杂志,2006,12(5):824-825.
[85]李艳玲,马桂敏.中药外洗联合壮医药线灸治疗掌跖脓疱病32例[J].上海中医药杂志,2008,42(10):52-53.
[86]吕琳，陈永红,韦金育.壮医药线点灸治疗脾虚证的临床疗效及机制研究[J].广西中医药,2006,(29)5:52-53.
[87]王红梅.阿维A联合雷公藤治疗掌跖脓疱病疗效观察[J].中国误诊学杂志,2007,7(13):2966
[88]袁晓玲.阿维A联合雷公藤治疗掌跖脓疱病32例临床观察[J].皮肤病与性病,2008,30(4):38-39
[2]李世德,张荣良,刘忠新.镍铬合金固定义齿致掌跖脓疱病一例[J].临床皮肤科杂志,1998,27(5):332
[3]皮超..金属节育环导致下唇剧痒27年一例[J].皮肤病与性病,2007,29(1):58
[4]段文利.协和医院首例报道铜过敏所致掌跖脓疱病.中国医药报,2009年1月13日第A04版
[5]倪容之主编,现代皮肤病治疗学[M].人民军医出版社,1994,500
[6] Nozawa H, Kishibe K, Takahara M,et al. Expression of cutaneouslymphocyte-associated antigen (CLA) in tonsillar T-cells and its inductionby in vitro stimulation with alpha-streptococci in patients with pustulosispalmaris et plantaris (PPP)[J].Clin Immunol,2005,116(1):42-53.
[7] Hubner AM,Tenbaum SP.Complete remission of palmoplantar pustulosisthrough Helicobacyer phlori eradication: a case report[J]. Clin ExpD-ermatol,2008,33(3):339-340
[8]马绍云,窦国华.中西医结合治疗掌跖脓疱病46例临床观察[J].甘肃中医,2001,14(10):45
[9]刘洪普,黄秀红.中医药治疗掌跖脓疱病研究进展.山东医药大学学报,2008,32(2):175-176.
[10]王争胜.六味洗剂配合窄谱UVB照射治疗掌跖脓疱病的疗效观察[J].甘肃中医学院学报,2010,27(4):42-43.
[11]张枫.人咬伤诱发掌跖脓疱病一例[J].皮肤病与性病,2005,27（2）：60.
[12] Cohen JD, Bournerias I, Buffar V, et al. Psoriasis induced by tumornecrosis factor-α antagonist therapy: a case series[J]. J Rheumatol,2007,34(2):380-385.
[13]张壤之,王景权.一家四代10人同患掌跖脓疱病[J].皮肤病与性病,1998,20(2):39.
[14] Edlund E, Johnsson U, Lidgren L, et al. Palmoplantar pustulosis andsternocostoclavicular arthro-osteitis[J]. Ann Rheum Dis,1988:47(10):809–815.
[15] Nymann P, Kollerup G, Jemec GBE, Grossmann E.Decreased bonemineral density in patients with pustulosis palmaris et plantaris[J].Dermatology,1996:192(4):307–311.
[16] Saez-Rodriguez M, Noda-Cabrera A, Garcia-Bustinduy M, Gul-meraMar-tin-Neda F, Dorta-Alom S, Escoda-Garcia M,et al. Palmo-plantar pustu-losis associated with gastric Helicobacter pyloriinfection[J]. Clin Exp Dermatol,2002:27(8):720.
[17] O’Doherty CJ, MacIntyre C. Palmoplantar pustulosis and Smoking[J].BMJ (Clinical Research Ed),1985:291(6499):861–864.
[18] Saez-Rodriguez M, Noda-Cabrera A, Alvarez-Tejera S, Gulmer-aMartinNeda F, Dorta-Alom S, Escoda-Garcia M,et al. The role ofpsychological factors in palmoplantar pustulosis [J].J Eur Acad Derma-tolVenereol,2002:16(4):325–327.
[19] Camp RDR. Champion RH, et al. Psoriasis In:Textbook of Dermatology.6thed. Oxford: Blackwell Science,1998.1589-1649.
[20]王侠生,廖康煌.杨国亮皮肤病学[M].上海:上海科学技术出版社,2005:582-583.
[21]杨明霞,杨维玲,李鹤玉,等.掌跖脓疱病不属于银屑病几种疾病外周血单核细胞对OK-432增殖反应的比较[J].哈尔滨医科大学学报,2009,43(4):368-371
[22]李秉煦,麦幕霞,郭丙堂.掌跖脓疱病免疫学观察[J].临床皮肤科杂志,1990(19):231-232.
[23]商刚，姚大芳.中草药治疗掌跖脓疱病临床疗效的理论研究[J].航空航天医药,2000,11(2):66-69.
[24]曹海鹏,朱桢,齐凤琴,富学东.复方甘草酸苷片联合复方氟米松软膏治疗掌跖脓疱病45例疗效观察[J].中国煤炭工业医学杂志,2010,13(3):428-429.
[25]刘俊礼,赵荣涛.掌跖脓疱病患者免疫指标测定及其意义[J].吉林医学院学报,1999,19(1):27-29.
[26] Torii H,Nakagawa H, Ishibashi Y,et al. Genetic polymorphisms in thefourth component of complement (C4) and in properdin factor B (BF) inJapanese patients with palmoplantar pustulosis[J]. J Dermatol,1992,19(6):353-355.
[27]吴秀忠，郭高田，王应俊等.环孢素A治疗掌跖脓疱病及血清细胞因子检测[J].中华皮肤科杂志,1997，30（2）：135.
[28] Rosen K, Jontell M, Mobacken H, et al. Epidermal Langerhans cells inpatients with pustulosis palmop-lantaris treated with etretinate oretretinate methoxsalen photochemotherapy[J]. Acta Derm Venereol,1988,68(3):218-223.
[29]史飞,赵庆利,王毅侠等.蔡瑞康教授治疗掌跖脓疱病经验[J].中国中西医结合皮肤性病学杂志,2004,3(4):196-197
[30]乔宏,刘灵,马栓全.无菌性脓疱类皮肤病中医治疗体[J].现代中医药,2006,26(1):13-14.
[31]王禾,王萍,陈凯.辨证治疗掌跖脓疱病18例[J].北京中医,2004,23(4):223-224.
[32]马怀东，田连迎.活血清热散治疗掌跖脓疱病60例[J].河北中医,2001：23(9):672.
[33] Sonozaki H, Kawashima M, Hongo O, et al. Incidence of arthroosteitis inpatients with pustulosis palmaris et plantaris [J]. Ann Rheum Dis,1981,40(6):554-557.
[34]张江林,黄烽.掌跖脓疱病性关节炎影像学表现[J].中国医学影像技术,2005,21(9):1427-1429.
[35]屈丽娜，邵娟，张福仁.掌跖脓疱病伴胸肋关节炎1例[J].实用皮肤病学杂志,2009,2(3):132.
[36]曹宇，闵仲生，张美华.掌跖脓疱病伴发前胸壁综合症[J].临床皮肤科杂志,2010,39(5):294-296
[37]杨蓉娅,唐玉，王文岭，等.掌跖脓疱病伴骨关节损害2例[J].临床皮肤科杂志，2001,30(1):49。
[38] Hagforgen E,Michalsson K,Lundgren E et al.Women with palmoplanterpustulosis have disturbed calcium homeostasis and a high prevalence ofdiabetes mellitus and psychiatric disorders: A case control study [J].Dermatology,2005,1(8):40-41．
[39]刘东海.甲亢伴掌跖脓疱病1例[J].罕少疾病杂志，2004.11(1):59-60.
[40]杨克健,惠艳.维胺脂胶囊治疗掌跖脓疱病疗效观察[J].中华皮肤科杂志,2003,36(4):220.
[41]李媛媛，钟文俊，池丽俏.异维A酸联合雷公藤治疗掌跖脓疱病疗效观察.中国社区医师,16版.
[42]徐薇，杨高云，赵俊英.异维A酸胶丸合并卤米松软膏治疗掌跖脓疱病临床疗效观察[J].中国医刊,2010,45(9):63-64.
[43] Wiegand UW, Chou RC. Pharmacokinetics of acitretin and etretinate [J]. JAm Acad Dermatol,1998,39(2):25-33.
[44] Gerger JM. Efficacy of acitretin in severe psoriasis[J]. Skin therapyletter,2003,8(4):1-3,7.
[45] GronhojLarsen F, SteinkjerB, Jakobsen P,et al. Acitretin is converted toetretinate only during concomitant alcohol intake [J]. Br J Dermatol,2000,143(6):1164-1169.
[46]庞晓文,王玉颖,赵密萍.阿维A治疗掌跖脓疱病临床疗效观察[J].临床皮肤科杂志,2007,36(2):117
[47] Rood MJ, Lavrijsen SP, Huizinga TW. Acitretinrelated Ossification [J].JRheumatol,2007,34(4):837-838.
[48] West MR, Page JM, Turner DM, et al. Simple assays of retinoid activity aspotential screens for compounds that may be useful in treatment ofpsoriasis[J]. J Invest Dermatol,1992,99(1):95-100.
[49]郭英军,李远宏,夏丽新,陈洪铎.芳维A酸乙酯胶囊治疗无菌性脓疱性皮肤病疗效观察[J].中国麻风皮肤病杂志,2007,23(3）：222-223.
[50]陈世义,李晓红,刘兵,马刚.芳维A酸乙酯治疗掌跖脓疱病临床分析[J].吉林大学学报,2003,39(4):504.
[51] Kumada H.Long-term treatment of chronic hepatitis C with glycyrrhizinin stronger neo-minophagen C(SNMC) for preventing liver cirrhosis andhepatocellular carcinoma[J]. Oncology,2002,62Suppl:94–100.
[52] Kroes BH, Beukelman CJ,Vanden Berg AJ, et al. Inhibition of humancomplement by beta glycyrrhetimic acid[J]. Immunology,1997,90(1):115-120.
[53]李萍,冯世军,马敬,王雪燕.复方甘草酸苷片治疗掌跖脓疱病疗效观察[J].河北中医,2007,29(8)742-743.
[54]孙鹤春,姜洪起,于延.复方甘草酸苷联合雷公藤治疗掌跖脓疱病疗效观察[J].中国皮肤性病学杂志,2008,22(8):475-476.
[55]安洪艳,雷公藤多甙治疗掌跖脓疱病临床疗效观察[J].中国冶金工业医学杂志,2008,25(5):572.
[56]张彪.掌跖脓疱病治疗现状[J].中国误诊学杂志,2010,10(31):7577-7579.
[57]朱学骏,顾有守,沈丽玉.实用皮肤性病治疗学[M],北京:北京医科大学中国协和医科大学联合出版社,1996:59-60.
[58]吴秀忠,郭高田,王应俊,于天周,肖国民.环孢素A治疗掌跖脓疱病及血清细胞因子检测[J].中华皮肤科杂志,1997,30(2):135.
[59]刘春梅,丁秋允,赵建伟，等.卡介苗素联合复方青黛胶囊治疗掌跖脓疱病临床观察[J].中国麻风皮肤病杂志,2007,23(7):640.
[60]邓列华，林泽，陈贤丰.左旋咪唑治疗掌跖脓疱病[J].岭南皮肤性病科杂志,1995,(4):17-18.
[61] Kanda N, Enomoto U, Watanabe S.Anti-mycotice suppress in terleukin-4and interleukin-5production in anti-CD3plus anti-CD28-stimulated Tcells from patients with atopic dermatitis[J].J Invest Dermatol,2001,117(6):1635-1646.
[62]姚志远，尤立平，张立新，等.伊曲康唑治疗掌跖脓疱病临床观察[J].临床皮肤科杂志,2004,33(7):441-442.
[63]庞晓文,杨雪琴,江丽,等.甘草酸二胺联合米诺环素治疗掌跖脓疱病[J].中华皮肤科杂志,2002,35(6):438.
[64] Owen CM, Chalmers RJ, Sullivan T, et al. Antistreptococcal interventionsfor guttate and chronic plaque psoriasis. Cochrane Database Syst Rev,2000:(2):CD001976.
[65]姜红军，甲砜霉素治疗掌跖脓疱病41例[J].中国皮肤性病学杂志,2007，21(7)：440
[66]王亮春,赵天恩.氨苯砜的皮肤科临床应用新进展[J].皮肤病与性病,2001,23(1):21.
[67]沈敏娟,匡钱华.黄柏洗剂治疗掌跖脓疱病60例[J].中华皮肤科杂志,2003,36(2):106.
[68]刘拥军,张健,李淑莲等.中药复方二白洗剂治疗掌跖脓疱病临床研究[J].中医药信息,2004,21(3):61-62.
[69]张春红,杜锡贤,张春敏.清热利湿饮治疗掌跖脓疱病35例[J].中国中西医结合皮肤性病学杂志,2004,(2):109.
[70]崔德彬,鲍海平.中西医结合治疗掌跖脓疱病50例疗效观察[J].中国皮肤性病学杂志,2006,20(7):419
[71] Duvic M, Asano AT, Hager C, et al. The pathogenesis of psoriasis andthe mechanism of action of tazarotene[J]. J Am Acad Dermatol,1998,39(4):129-133.
[72] Krochmal L, Wang JC, Patel B,et al.Topical corticosteroid compo-unding:effects on physicochemical stability and skin penetration rate [J].J Am Acad Derm,1989,21(5):979-984.
[73] Matsumoto K, Hashimoto K, Kiyoki M, et al. Effect of1,24Rdihy-droxyvitamin D3on the growth of human keratinocytes [J]. J Dermatol,1990,17(2):97-103.
[74]范雪莉,郑家润.1,25-二羟维生素D3和钙泊三醇对表皮细胞的免疫抑制作用[J].国外医学·皮肤性病学分册,1995,21(4):247-248.
[75]张俊，胡飞虎，郦黎明,等.他卡西醇软膏治疗27例掌跖脓疱病疗效观察[J].临床皮肤科杂志,2007,36(5):328-329.
[76]赵文，曹玉平.钙泊三醇加卤米他松封包治疗限局性无菌性脓疱病61例[J].中国医师进修杂志,2006,29(2):40-41.
[77]赵延海,杨红,刘轶平.窄谱中波紫外线治疗掌跖脓疱病疗效观察[J].中国中西医结合皮肤性病学杂志,2005,4（3）:187.
[78]李艳阳，杨学武，隋薇.窄谱中波紫外线照射治疗掌跖脓疱病疗效观察[J].中国麻风皮肤病杂志,2006,22(7):612.
[79]杨宝琦,赵娜,张福仁.银屑病光疗和光化学疗法的研究进展[J].中华皮肤科杂志,2005,38(3):195-197.
[80]张彪，兰广萍，胡本超，时念成.局部PUVA治疗掌跖脓疱病8例[J].中国麻风皮肤病杂志,2005,21(6):495.
[81]张宝牛,刘炯.90Sr-90Y敷贴器治疗掌跖脓疱病的临床应用[J].临床医药实践杂志,2007,16(7):593-584.
[82]尹伯元.临床核素治疗学[M].北京:人民军医出版社,2003:234-238.
[83]韩秀玲,刘业兰,周光英.得宝松穴位注射治疗掌跖脓疱病40例报告[J].山东医药,2007,47(6):39.
[84]邓文霞.曲安缩松穴位注射治疗掌跖脓疱病56例观察与护理[J].齐鲁护理杂志,2006,12(5):824-825.
[85]李艳玲,马桂敏.中药外洗联合壮医药线灸治疗掌跖脓疱病32例[J].上海中医药杂志,2008,42(10):52-53.
[86]吕琳，陈永红,韦金育.壮医药线点灸治疗脾虚证的临床疗效及机制研究[J].广西中医药,2006,(29)5:52-53.
[87]王红梅.阿维A联合雷公藤治疗掌跖脓疱病疗效观察[J].中国误诊学杂志,2007,7(13):2966
[88]袁晓玲.阿维A联合雷公藤治疗掌跖脓疱病32例临床观察[J].皮肤病与性病,2008,30(4):38-39